Cargando…
A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
BACKGROUND: Cachexia, a devastating syndrome in cancer patients, critically determines survival and life quality. It is characterized by impaired homeostasis of multiple organs including the liver, involves tissue wasting, and is conventionally diagnosed and classified by weight loss (WL). However,...
Autores principales: | Prokopchuk, Olga, Hermann, Chris D., Schoeps, Benjamin, Nitsche, Ulrich, Prokopchuk, Oleksii L., Knolle, Percy, Friess, Helmut, Martignoni, Marc E., Krüger, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061407/ https://www.ncbi.nlm.nih.gov/pubmed/33590974 http://dx.doi.org/10.1002/jcsm.12680 |
Ejemplares similares
-
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
por: Prokopchuk, Olga, et al.
Publicado: (2018) -
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
por: Mueller, Tara C., et al.
Publicado: (2016) -
The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
por: Schwarz, S., et al.
Publicado: (2017) -
Measurement of body mass by bioelectrical impedance analysis and computed tomography in cancer patients with malnutrition – a cross-sectional observational study
por: Mueller, Tara Catharina, et al.
Publicado: (2020) -
Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status
por: Chovsepian, Alexandra, et al.
Publicado: (2023)